Anticoagulation of pregnant women with mechanical heart valves.

PubWeight™: 2.22‹?› | Rank: Top 2%

🔗 View Article (PMID 12639202)

Published in Arch Intern Med on March 24, 2003

Authors

Jeffrey S Ginsberg1, Wee Shian Chan, Shannon M Bates, Scott Kaatz

Author Affiliations

1: Department of Medicine, McMaster University, Hamilton, Ontario, Canada. ginsbrgj@mcmaster.ca

Articles by these authors

Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med (2015) 10.86

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation (2011) 6.48

Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet (2011) 4.78

Instruments for evaluating education in evidence-based practice: a systematic review. JAMA (2006) 4.50

Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation (2012) 3.74

Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol (2002) 3.05

Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis. Ann Intern Med (2012) 2.91

D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study. Ann Intern Med (2015) 2.63

Nonheparin anticoagulants for heparin-induced thrombocytopenia. N Engl J Med (2013) 2.32

Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. Arch Intern Med (2007) 2.20

Evidence-based risk communication: a systematic review. Ann Intern Med (2014) 2.14

Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis: a randomized trial. Ann Intern Med (2013) 2.09

An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trial. Ann Intern Med (2006) 1.78

A randomized trial of diagnostic strategies after normal proximal vein ultrasonography for suspected deep venous thrombosis: D-dimer testing compared with repeated ultrasonography. Ann Intern Med (2005) 1.57

Detection of pulmonary emboli with 99mTc-labeled anti-D-dimer (DI-80B3)Fab' fragments (ThromboView). Am J Respir Crit Care Med (2011) 1.51

Congestive heart failure and QRS duration: establishing prognosis study. Chest (2002) 1.28

The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines. Can J Cardiol (2011) 1.25

Clinical and safety impact of an inpatient pharmacist-directed anticoagulation service. J Hosp Med (2011) 1.24

Comment on: editorial by Husted et al. "Non-vitamin K antagonist oral anticoagulants (NOACs): no longer new or novel". (Thromb Haemost 2014; 111: 781-782). Thromb Haemost (2014) 1.07

A population-based study of inferior vena cava filters in patients with acute venous thromboembolism. Arch Intern Med (2010) 1.04

Examining warfarin underutilization rates in patients with atrial fibrillation: Detailed chart review essential to capture contraindications to warfarin therapy. Thromb J (2008) 1.03

Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study. Ann Pharmacother (2005) 1.02

Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded. Haematologica (2012) 1.00

Potential drug-drug interactions in the outpatient setting. Med Care (2006) 0.96

Are brand-name and generic warfarin interchangeable? Multiple n-of-1 randomized, crossover trials. Ann Pharmacother (2005) 0.96

Outcomes and prognostic factors of systolic as compared with diastolic heart failure in urban America. Congest Heart Fail (2005) 0.96

The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society Guidelines Executive Summary. Can J Cardiol (2011) 0.88

Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial. Stroke (2012) 0.88

Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis. Am J Hematol (2008) 0.87

All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries. J Manag Care Pharm (2012) 0.86

Academic detailing to improve laboratory testing among outpatient medication users. Med Care (2007) 0.85

Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry). Am J Cardiol (2008) 0.84

Accuracy and usefulness of a clinical prediction rule and D-dimer testing in excluding deep vein thrombosis in cancer patients. Thromb Res (2008) 0.84

Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians. Can J Clin Pharmacol (2005) 0.83

Venous thromboembolism in pregnancy: diagnosis, management and prevention. Thromb Haemost (2009) 0.82

Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy: a study protocol. BMC Pregnancy Childbirth (2012) 0.82

Journal club 102: enhancing evidence-based medicine learning using a virtual journal club. J Grad Med Educ (2012) 0.81

Warfarin use in atrial fibrillation patients at low risk for stroke: analysis of the Michigan Anticoagulation Quality Improvement Initiative (MAQI(2)). J Thromb Thrombolysis (2014) 0.81

Opportunities for improvement in the diagnosis and treatment of heart failure. Clin Cardiol (2003) 0.80

Accuracy and safety of (99m)Tc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView®) in the diagnosis of deep vein thrombosis: a phase II study. Thromb Res (2012) 0.79

The effect of prothrombotic blood abnormalities on risk of deep vein thrombosis in users of hormone replacement therapy: a prospective case-control study. Clin Appl Thromb Hemost (2010) 0.79

Use of warfarin for venous thromboembolism prophylaxis following knee and hip arthroplasty: results of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2). J Thromb Thrombolysis (2013) 0.79

North American and British guidelines for anti-thrombotic therapy: are we reaching consensus? Thromb Res (2009) 0.79

"ProC Global": a functional screening test that predicts recurrent venous thromboembolism. Thromb Haemost (2005) 0.77

Low-dose warfarin in rehabilitating stroke survivors. Thromb Res (2002) 0.76

All-cause and disease-related health care costs associated with recurrent venous thromboembolism. Thromb Haemost (2013) 0.76

2009 evidence-based clinical practice guidelines for diagnosing a first episode of lower extremities deep vein thrombosis in ambulatory outpatients. Pol Arch Med Wewn (2009) 0.76

Management of oral anticoagulation in patients undergoing minor dental procedures. J Mich Dent Assoc (2012) 0.76

CURB-65 and SMRT-CO in the prediction of early transfers to the intensive care unit among patients with community-acquired pneumonia initially admitted to a general ward. J Hosp Med (2011) 0.75

Persistent right ventricular dysfunction increased risk for recurrent venous thromboembolism after acute pulmonary embolism. ACP J Club (2007) 0.75

Weekly risk of venous thromboembolism recurrence in patients receiving oral anticoagulants. Curr Med Res Opin (2014) 0.75

Preventing thrombophilia-related complications of pregnancy. Expert Rev Hematol (2009) 0.75

Performance of new anticoagulants for thromboprophylaxis in patients undergoing hip and knee replacement surgery. Pharmacotherapy (2012) 0.75

Ulnar deep venous thrombosis in a professional baseball pitcher: a case report. Am J Sports Med (2007) 0.75

What do medical records tell us about potentially harmful co-prescribing? Jt Comm J Qual Patient Saf (2007) 0.75

Should patients on warfarin for 3 months for idiopathic proximal deep venous thrombosis receive bridging therapy precolonoscopy (with expected biopsy)? Med Clin North Am (2003) 0.75

Human-derived D-dimer for external quality assessment: results of four surveys in Ontario. Am J Clin Pathol (2008) 0.75

Women's values and preferences and health state valuations for thromboprophylaxis during pregnancy: A cross-sectional interview. Thromb Res (2016) 0.75

Acute coronary syndromes: a focus on thrombin. J Invasive Cardiol (2002) 0.75

Should D-dimer testing be used to predict the risk of recurrence after discontinuation of anticoagulant therapy for a first unprovoked episode of venous thromboembolism? Pol Arch Med Wewn (2009) 0.75

Angiotensin converting enzyme inhibitors and beta-blockers in African Americans with heart failure. Ethn Dis (2003) 0.75